California takes on pharma giants with plans to sell its own insulin

What's new in pharma

October 17, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | California takes on pharma giants with plans to sell its own insulin Insulin has been a flashpoint in the national debate over the cost of prescription medicines and some people have rationed their supplies. By Ed Silverman STAT+ | Turkey antitrust regulator fines several big drugmakers for 'no-poach' agreements The regulator noted that these practices undermine competition in the pharmaceutical sector and disrupt employee mobility. By Ed Silverman STAT+ | FDA announces first nine recipients of priority drug review vouchers Agency promises one- to two-month drug reviews for Sanofi's diabetes drug and Regeneron gene therapy, among others By Lizzy Lawrence Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Joe Kennedy III split with uncle RFK Jr. over 'grave concerns' about U.S. health At the STAT Summit, the former Democratic congressman from Massachusetts shared his concerns about the recent Medicaid cuts. By Sarah Todd

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser